Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: Proceedings from a multidisciplinary research consensus panel

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 5, 2011, Pages 587-593

  Siskin, Gary P ^a   Haskal, Ziv J ^b   McLennan, Gordon ^c   Dake, Michael D ^d   Haacke, E Mark ^e   McDonald, Sandy ^f   Royal III, Walter ^b   Vedantham, Suresh ^g   Hubbard, David ^h   Sclafani, Salvatore J ⁱ   Andrews, R Torrance ^j   Sauder, Heidi ^h  

^a ALBANY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY   (United States)

^f Barrie Vascular Imaging   (Canada)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Applied fMRI Institute   (United States)

ⁱ KINGS COUNTY HOSPITAL CENTER   (United States)

^j SWEDISH MEDICAL CENTER   (United States)

more..

Author keywords

CCSVI; central nervous system; chronic cerebrospinal venous insufficiency; CNS; MS; multiple sclerosis

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; FINGOLIMOD; GILENYA; GLATIRAMER; MITOXANTRONE; NATALIZUMAB; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ARTICLE; CARDIOTOXICITY; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CHRONIC VEIN INSUFFICIENCY; DOPPLER FLOWMETRY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; FLU LIKE SYNDROME; HUMAN; INJECTION SITE REACTION; MULTIPLE SCLEROSIS; PHLEBOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUALITY OF LIFE; RETINA EDEMA; RISK FACTOR; TREATMENT RESPONSE; VEIN DISEASE;

EID: 79955387155     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.03.007     Document Type: Editorial

References (65)

1. E.M. Frohman, M.K. Racke, and C.S. Raine Multiple sclerosis the plaque and its pathogenesis N Engl J Med 354 2006 942 955
2. P. Fontoura, and H. Garren Multiple sclerosis therapies: molecular mechanisms and future Results Probl Cell Differ 51 2010 259 285
3. M. Ali Sahraian, and A. Eshagi Role of MRI in diagnosis and treatment of multiple sclerosis Clin Neurol Neurosurg 112 2010 609 615
4. J.L. Jones, and A.J. Coles New treatment strategies in multiple sclerosis Exp Neurol 225 2010 34 39
5. J.M. Charcot Histology of "sclerose en plaque" (in French) Gazette Hosp (Paris) 41 1868 554 566 [French]
6. T. Fog The topography of plaques in multiple sclerosis with special reference to cerebral plaques Acta Neurol Scand 15 Suppl 1965 1 161
7. T.J. Putnam Lesions of encephalomyelitis and multiple sclerosis Venous thrombosis as the primary alteration JAMA 108 1937 1477
8. P. Zamboni The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis J R Soc Med 99 2006 589 593 (Pubitemid 44876813)
9. P. Zamboni, P. Galeotti, and E. Menegtti Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis J Neurol Neurosurg Psychiatry 80 2009 392 399
10. P. Zamboni, R. Galeotti, and E. Menegatti A prospective open label study of endovascular treatment of chronic cerebrospinal venous insufficiency J Vasc Surg 50 2009 1348 1358
11. S.V. Ramagopalan, R. Dobson, U.C. Meier, and G. Giovannoni Multiple sclerosis: risk factors, prodromes, and potential causal pathways Lancet Neurol 9 2010 727 739
12. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis Part I: the role of infection Ann Neurol 61 2007 288 299 (Pubitemid 46676728)
13. A. Ascherio, and K.L. Munger Environmental risk factors for multiple sclerosis Part II: noninfectious factors Ann Neurol 61 2007 504 513 (Pubitemid 47068132)
14. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838 (Pubitemid 44969183)
15. H.F. McFarland, and R. Martin Multiple sclerosis: a complicated picture of autoimmunity Nat Immunol 8 2007 913 919 (Pubitemid 47300005)
16. C.F. Lucchinetti, W. Bruck, and H. Lassmann Evidence for pathogenic heterogeneity in multiple sclerosis Ann Neurol 56 2004 308
17. P. Nilsson, E.M. Larsson, P. Maly-Sundgren, R. Perfekt, and M. Sandberg-Wollheim Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up J Neurol 252 2005 396 402 (Pubitemid 40576901)
18. C. Shaw, C. Chapman, and H. Butzkueven How to diagnosis multiple sclerosis and what are the pitfalls Int Med J 39 2009 792 799
19. F.D. Lublin Clinical features and diagnosis of multiple sclerosis Neurol Clin 23 2005 1 15 (Pubitemid 40126912)
20. L.D. Jacobs, D.L. Cookfair, and R.A. Rudick Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol 39 1996 285 294 (Pubitemid 26100751)
21. K.P. Johnson, B.R. Brooks, and J.A. Cohen Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial The Copolymer 1 Multiple Sclerosis Study Group Neurology 45 1995 1268 1276
22. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis Lancet 352 1998 1498 1504
23. M. Hutchinson, L. Kappos, and P.A. Calabresi The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL J Neurol 256 2009 405 415
24. L. Kappos, E.W. Radue, and P. O'Connor A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N Engl J Med 362 2010 387 401
25. H.P. Hartung, R. Gonsette, and N. Konig Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial Lancet 360 2002 2018 2025 (Pubitemid 36026580)
26. D. Kidd, F. Barkhof, and R. McConnell Cortical lesions in MS Brain 122 1999 17 26
27. J.W. Dawson The histology of disseminated sclerosis Trans R Soc Edinb 50 1916 517
28. P. Zamboni, G. Consorti, and R. Galeotti Venous collateral circulation of the extracranial cerebrospinal outflow routes Curr Neurovasc Res 6 2009 204 212
29. Y. Ge, M. Law, G. Johnson, J. Herbert, J.S. Babb, L.J. Mannon, and R.I. Grossman Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity AJNR Am J Neuroradiol 26 2005 1539 1547 (Pubitemid 43733458)
30. M. Inglese, S. Adhya, and G. Johnson Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis J Cereb Blood Flow Metab 28 2008 164 171
31. M. Law, A.M. Saindane, and Y. Ge Microvascular abnormality in relapsing-remitting MSL perfusion MR imaging findings in normal-appearing white matter Radiology 231 2004 645 652 (Pubitemid 38668078)
32. P. Zamboni, E. Menegatti, and Weinstock-Guttman The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics Functional Neurol 24 2009 133 138
33. M. Ursino, and C.A. Lodi A simple mathematical model of the interaction between intracranial pressure and cerebral hemodynamics J Appl Physiol 82 1997 1256 1269 (Pubitemid 27172329)
34. P. Zamboni, E. Menegatti, and I. Bartolomei Intracranial venous haemodynamics in MS Curr Neurovasc Res 4 2007 252 258
35. P. Zamboni, S. Lanzara, and F. Mascoli Inflammation in venous disease Int Angiol 27 2008 361 369
36. F. Schelling Damaging venous reflux into the skull or spine: relevance to multiple sclerosis Med Hypotheses 21 1986 141 148 (Pubitemid 17201924)
37. D.G. Talbert Raised venous pressure as a factor in multiple sclerosis Med Hypotheses 70 2008 1112 1117
38. J.B. West, K. Tsukimoto, and O. Matheu-Costello Stress failure in pulmonary capillaries J Appl Physiol 70 1991 1731 1742
39. A.V. Singh, and P. Zamboni Anomalous venous blood flow and iron deposition in multiple sclerosis J Cereb Blood Flow Metabol 29 2009 1867 1878
40. B. Todrich, J.M. Pasquini, and C.I. Garcia Oligodendrocytes and myelination: the role of iron GLIA 57 2009 467 478
41. S.M. Grant, J.A. Wiesinger, and J.L. Beard Iron-deficient mice fail to develop autoimmune encephalomyelitis J Nutr 133 2003 2635 2638 (Pubitemid 36935983)
42. C. Sfagos, A.C. Makis, and A. Chaidos Serum ferritin, transferring, and soluble transferrin receptor levels in multiple sclerosis patients Mult Scler 11 2005 272 275 (Pubitemid 40775181)
43. P. Zamboni, E. Menegatti, and R. Galeotti The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis J Neurol Sci 282 2009 21 27
44. E. Menegatti, V. Genova, and M. Tessari The reproducibility of color Doppler in chronic cerebrospinal venous insufficiency associated with multiple sclerosis Int Angiol 2 2010 121 126
45. M. Simka, J. Kostecki, M. Zaniewski, E. Majewski, and M. Hartel Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in patients with MS Int Angiol 2 2010 109 114
46. M.H. Al-Omari, and L.A. Rousan Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis Int Angiol 2 2010 115 120
47. F. Doepp, F. Paul, and J.M. Valdueza No cerebrospinal venous congestion in patients with multiple sclerosis Ann Neurol 68 2010 173 183
48. C.W. Tnoia, R.H. Beneict, B. Weinstok-Guttman, A.J. Fabiano, and R. Bakshi MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis J Neurol Sci 234 2005 17 24 (Pubitemid 40910338)
49. R. Zivadinov, and R. Bakshi Role of MRI in multiple sclerosis I Brain and spinal cord atrophy Front Biosci 9 2004 647 664
50. R. Zivadinov, C. Schirda, and M.G. Dwyer Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study Int Angiol 29 2010 158 175
51. E.M. Haacke, M. Makki, and Y. Ge Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging J Magn Reson Imaging 29 2009 537 544
52. E.M. Haacke, S. Mittal, Z. Wu, J. Neelavalli, and N.Y.C. Cheng Susceptibility-weighted imaging: technical aspects and clinical applications, part 1 AJNR Am J Neuroradiol 30 2009 19 30
53. E.M. Haacke, N.Y.C. Cheng, and J.H. Michael Imaging iron stores in the brain using magnetic resonance imaging Mag Reson Imaging 23 2005 1 25 (Pubitemid 40269946)
54. R. Agid, I. Shelef, J.N. Scott, and R.I. Farb Imaging of the intracranial venous system Neurologist 14 2008 12 22
55. D. Hojnacki, P. Zamboni, and A. Lopez-Soriano Use of neck magnetic resonance venography, Doppler sonography, and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls Int Angiol 29; 2010 127 139
56. P. Sundstrom, A. Wahlin, and K. Ambarki Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study Ann Neurol 68 2010 255 259
57. M.P. Wattjes, B.W. van Oosten, and W.L. de Graaf No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study J Neurol Neurosurg Psychiatry 82 2011 429 435
58. B.C. Healy, D. Ikle, E.A. Macklin, and G. Cutter Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint Mult Scler 16 2010 840 847
59. L. Balcer Clinical outcome measures for research in multiple sclerosis J Neuroophthalmol 21 2001 296 301 (Pubitemid 34027533)
60. B.G. Vickrey, R.D. Hays, R. Harooni, L.W. Myers, and G.W. Ellison A health-related quality of life measure for multiple sclerosis Qual Life Res 4 1995 187 206
61. J.F. Kuertzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444 1452
62. G.R. Cutter, M.L. Baier, and R.A. Rudick Development of a multiple sclerosis functional composite as a clinical trial outcome measure Brain 122 1999 871 882 (Pubitemid 29219261)
63. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, and A.D. Steinberg The fatigue severity scale Application to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 1989 1121 1123 (Pubitemid 19246303)
64. A. Dumitriu, and B.O. Popescu Placebo effects in neurological diseases J Med Life 3 2010 114 121
65. T. Ludya, M. Kazibudzki, and S. Simka Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology 25 2010 286 295